2022: Page 2
The company is showcasing work it is doing with new partners Horizon Discovery, BioLegend, Nexcelom Bioscience, and Omni International, which ranges from automation, liquid handling, high-content screening, cell painting, multimode detection, gene editing tools, and functional genomic screening services and libraries. The company is also touting its work in cell counting, antibodies for flow cytometry, recombinant proteins, and no-wash immunoassay kits, PerkinElmer said. February 6, 2022